ArticleClinical and experimental immunology2010

An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.

D Ly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.